Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U8OA
|
|||
Former ID |
DNC009150
|
|||
Drug Name |
(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine
|
|||
Synonyms |
CHEMBL501620; (E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine; SCHEMBL15091007; SCHEMBL15091006; QHUQCHMVBGZYHI-ONEGZZNKSA-N; ZINC40424901; BDBM50267274
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H12N2
|
|||
Canonical SMILES |
CC=CC1=NC(=CC(=C1)C)N
|
|||
InChI |
1S/C9H12N2/c1-3-4-8-5-7(2)6-9(10)11-8/h3-6H,1-2H3,(H2,10,11)/b4-3+
|
|||
InChIKey |
QHUQCHMVBGZYHI-ONEGZZNKSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nitric-oxide synthase inducible (NOS2) | Target Info | Inhibitor | [1] |
BioCyc | Citrulline-nitric oxide cycle | |||
KEGG Pathway | Arginine biosynthesis | |||
Arginine and proline metabolism | ||||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
HIF-1 signaling pathway | ||||
Peroxisome | ||||
Salmonella infection | ||||
Pertussis | ||||
Leishmaniasis | ||||
Chagas disease (American trypanosomiasis) | ||||
Toxoplasmosis | ||||
Amoebiasis | ||||
Tuberculosis | ||||
Pathways in cancer | ||||
Small cell lung cancer | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | IL12-mediated signaling events | |||
Alpha9 beta1 integrin signaling events | ||||
ATF-2 transcription factor network | ||||
IL23-mediated signaling events | ||||
Signaling mediated by p38-alpha and p38-beta | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | ROS production in response to bacteria | |||
Nitric oxide stimulates guanylate cyclase | ||||
WikiPathways | Type II interferon signaling (IFNG) | |||
Spinal Cord Injury | ||||
AGE/RAGE pathway | ||||
Effects of Nitric Oxide |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fl... J Med Chem. 2009 Apr 23;52(8):2443-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.